{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:18:47Z","timestamp":1790644727587,"version":"4.1.0"},"reference-count":189,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Education and National University Health System"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12035-019-01719-1","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T13:02:51Z","timestamp":1564491771000},"page":"372-392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Pleotropic Roles of Autotaxin in the Nervous System Present Opportunities for the Development of Novel Therapeutics for Neurological Diseases"],"prefix":"10.1007","volume":"57","author":[{"given":"Deron R.","family":"Herr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wee Siong","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. L.","family":"Satish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9756-7772","authenticated-orcid":false,"given":"Wei-Yi","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"issue":"4","key":"1719_CR1","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/S0021-9258(18)45911-X","volume":"267","author":"ML Stracke","year":"1992","unstructured":"Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E, Liotta LA (1992) Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 267(4):2524\u20132529","journal-title":"J Biol Chem"},{"issue":"2","key":"1719_CR2","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1074\/jbc.272.2.996","volume":"272","author":"T Clair","year":"1997","unstructured":"Clair T, Lee HY, Liotta LA, Stracke ML (1997) Autotaxin is an exoenzyme possessing 5\u2032-nucleotide phosphodiesterase\/ATP pyrophosphatase and ATPase activities. J Biol Chem 272(2):996\u20131001. https:\/\/doi.org\/10.1074\/jbc.272.2.996","journal-title":"J Biol Chem"},{"issue":"42","key":"1719_CR3","doi-asserted-by":"publisher","first-page":"39436","DOI":"10.1074\/jbc.M205623200","volume":"277","author":"A Tokumura","year":"2002","unstructured":"Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, Fukuzawa K (2002) Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 277(42):39436\u201339442. https:\/\/doi.org\/10.1074\/jbc.M205623200","journal-title":"J Biol Chem"},{"issue":"3\u20134","key":"1719_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10555-011-9319-7","volume":"30","author":"AJ Houben","year":"2011","unstructured":"Houben AJ, Moolenaar WH (2011) Autotaxin and LPA receptor signaling in cancer. Cancer Metastasis Rev 30(3\u20134):557\u2013565. https:\/\/doi.org\/10.1007\/s10555-011-9319-7","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"1719_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1021\/acschemneuro.8b00057","volume":"9","author":"DR Herr","year":"2018","unstructured":"Herr DR, Ong JH, Ong WY (2018) Potential therapeutic applications for inhibitors of autotaxin, a bioactive lipid-producing lysophospholipase D, in disorders affecting the nervous system. ACS Chem Neurosci 9(3):398\u2013400. https:\/\/doi.org\/10.1021\/acschemneuro.8b00057","journal-title":"ACS Chem Neurosci"},{"key":"1719_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev.pharmtox.010909.105753","volume":"50","author":"JW Choi","year":"2010","unstructured":"Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST et al (2010) LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 50:157\u2013186. https:\/\/doi.org\/10.1146\/annurev.pharmtox.010909.105753","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3\u20134","key":"1719_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.prostaglandins.2009.02.002","volume":"91","author":"ME Lin","year":"2010","unstructured":"Lin ME, Herr DR, Chun J (2010) Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat 91(3\u20134):130\u2013138. https:\/\/doi.org\/10.1016\/j.prostaglandins.2009.02.002","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"13","key":"1719_CR8","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1128\/MCB.02419-05","volume":"26","author":"LA van Meeteren","year":"2006","unstructured":"van Meeteren LA, Ruurs P, Stortelers C, Bouwman P, van Rooijen MA, Pradere JP, Pettit TR, Wakelam MJ et al (2006) Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol Cell Biol 26(13):5015\u20135022. https:\/\/doi.org\/10.1128\/MCB.02419-05","journal-title":"Mol Cell Biol"},{"issue":"35","key":"1719_CR9","doi-asserted-by":"publisher","first-page":"25822","DOI":"10.1074\/jbc.M605142200","volume":"281","author":"M Tanaka","year":"2006","unstructured":"Tanaka M, Okudaira S, Kishi Y, Ohkawa R, Iseki S, Ota M, Noji S, Yatomi Y et al (2006) Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem 281(35):25822\u201325830. https:\/\/doi.org\/10.1074\/jbc.M605142200","journal-title":"J Biol Chem"},{"issue":"7","key":"1719_CR10","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1194\/jlr.R046458","volume":"55","author":"YC Yung","year":"2014","unstructured":"Yung YC, Stoddard NC, Chun J (2014) LPA receptor signaling: pharmacology, physiology, and pathophysiology. J Lipid Res 55(7):1192\u20131214. https:\/\/doi.org\/10.1194\/jlr.R046458","journal-title":"J Lipid Res"},{"issue":"8","key":"1719_CR11","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1038\/s41380-018-0053-1","volume":"23","author":"Carine Thalman","year":"2018","unstructured":"Thalman C, Horta G, Qiao L, Endle H, Tegeder I, Cheng H, Laube G, Sigrudsson T et al (2018) Synaptic phospholipids as a new target for cortical hyperexcitability and E\/I balance in psychiatric disorders. Mol Psychiatry. 2018 Aug;23(8):1699-1710. https:\/\/doi.org\/10.1038\/s41380-018-0053-1 .","journal-title":"Molecular Psychiatry"},{"issue":"36","key":"1719_CR12","doi-asserted-by":"publisher","first-page":"33697","DOI":"10.1074\/jbc.M104441200","volume":"276","author":"I Ishii","year":"2001","unstructured":"Ishii I, Friedman B, Ye X, Kawamura S, McGiffert C, Contos JJ, Kingsbury MA, Zhang G et al (2001) Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)\/EDG-3. J Biol Chem 276(36):33697\u201333704. https:\/\/doi.org\/10.1074\/jbc.M104441200","journal-title":"J Biol Chem"},{"issue":"24","key":"1719_CR13","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.1073\/pnas.97.24.13384","volume":"97","author":"JJ Contos","year":"2000","unstructured":"Contos JJ, Fukushima N, Weiner JA, Kaushal D, Chun J (2000) Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci U S A 97(24):13384\u201313389. https:\/\/doi.org\/10.1073\/pnas.97.24.13384","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"1719_CR14","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.1128\/mcb.22.19.6921-6929.2002","volume":"22","author":"JJ Contos","year":"2002","unstructured":"Contos JJ, Ishii I, Fukushima N, Kingsbury MA, Ye X, Kawamura S, Brown JH, Chun J (2002) Characterization of lpa(2) (Edg4) and lpa(1)\/lpa(2) (Edg2\/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol Cell Biol 22(19):6921\u20136929. https:\/\/doi.org\/10.1128\/mcb.22.19.6921-6929.2002","journal-title":"Mol Cell Biol"},{"issue":"12","key":"1719_CR15","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1091\/mbc.E08-03-0316","volume":"19","author":"Z Lee","year":"2008","unstructured":"Lee Z, Cheng CT, Zhang H, Subler MA, Wu J, Mukherjee A, Windle JJ, Chen CK et al (2008) Role of LPA4\/p2y9\/GPR23 in negative regulation of cell motility. Mol Biol Cell 19(12):5435\u20135445. https:\/\/doi.org\/10.1091\/mbc.E08-03-0316","journal-title":"Mol Biol Cell"},{"issue":"21","key":"1719_CR16","doi-asserted-by":"publisher","first-page":"17608","DOI":"10.1074\/jbc.M111.330183","volume":"287","author":"ME Lin","year":"2012","unstructured":"Lin ME, Rivera RR, Chun J (2012) Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain. J Biol Chem 287(21):17608\u201317617. https:\/\/doi.org\/10.1074\/jbc.M111.330183","journal-title":"J Biol Chem"},{"issue":"6","key":"1719_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/intimm\/dxv072","volume":"28","author":"E Hata","year":"2016","unstructured":"Hata E, Sasaki N, Takeda A, Tohya K, Umemoto E, Akahoshi N, Ishii S, Bando K et al (2016) Lysophosphatidic acid receptors LPA4 and LPA6 differentially promote lymphocyte transmigration across high endothelial venules in lymph nodes. Int Immunol 28(6):283\u2013292. https:\/\/doi.org\/10.1093\/intimm\/dxv072","journal-title":"Int Immunol"},{"issue":"7038","key":"1719_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature03505","volume":"435","author":"X Ye","year":"2005","unstructured":"Ye X, Hama K, Contos JJ, Anliker B, Inoue A, Skinner MK, Suzuki H, Amano T et al (2005) LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 435(7038):104\u2013108. https:\/\/doi.org\/10.1038\/nature03505","journal-title":"Nature"},{"issue":"6","key":"1719_CR19","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.fertnstert.2011.02.024","volume":"95","author":"X Ye","year":"2011","unstructured":"Ye X, Herr DR, Diao H, Rivera R, Chun J (2011) Unique uterine localization and regulation may differentiate LPA3 from other lysophospholipid receptors for its role in embryo implantation. Fertil Steril 95(6):2107\u20132113, 2113 e2101-2104. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.02.024","journal-title":"Fertil Steril"},{"issue":"3","key":"1719_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.fertnstert.2011.12.004","volume":"97","author":"X Ye","year":"2012","unstructured":"Ye X, Diao H, Chun J (2012) 11-deoxy prostaglandin F(2alpha), a thromboxane A2 receptor agonist, partially alleviates embryo crowding in Lpar3((\u2212\/\u2212)) females. Fertil Steril 97(3):757\u2013763. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.12.004","journal-title":"Fertil Steril"},{"issue":"3","key":"1719_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/ng.84","volume":"40","author":"SM Pasternack","year":"2008","unstructured":"Pasternack SM, von Kugelgen I, Al Aboud K, Lee YA, Ruschendorf F, Voss K, Hillmer AM, Molderings GJ et al (2008) G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nat Genet 40(3):329\u2013334. https:\/\/doi.org\/10.1038\/ng.84","journal-title":"Nat Genet"},{"issue":"3","key":"1719_CR22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1600-0625.2008.00788.x","volume":"18","author":"Y Shimomura","year":"2009","unstructured":"Shimomura Y, Garzon MC, Kristal L, Shapiro L, Christiano AM (2009) Autosomal recessive woolly hair with hypotrichosis caused by a novel homozygous mutation in the P2RY5 gene. Exp Dermatol 18(3):218\u2013221. https:\/\/doi.org\/10.1111\/j.1600-0625.2008.00788.x","journal-title":"Exp Dermatol"},{"issue":"5","key":"1719_CR23","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/humu.21235","volume":"31","author":"S Shinkuma","year":"2010","unstructured":"Shinkuma S, Akiyama M, Inoue A, Aoki J, Natsuga K, Nomura T, Arita K, Abe R et al (2010) Prevalent LIPH founder mutations lead to loss of P2Y5 activation ability of PA-PLA1alpha in autosomal recessive hypotrichosis. Hum Mutat 31(5):602\u2013610. https:\/\/doi.org\/10.1002\/humu.21235","journal-title":"Hum Mutat"},{"issue":"2","key":"1719_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1365-2230.2010.03944.x","volume":"36","author":"S Nahum","year":"2011","unstructured":"Nahum S, Morice-Picard F, Taieb A, Sprecher E (2011) A novel mutation in LPAR6 causes autosomal recessive hypotrichosis of the scalp. Clin Exp Dermatol 36(2):188\u2013194. https:\/\/doi.org\/10.1111\/j.1365-2230.2010.03944.x","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"1719_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.plipres.2007.02.001","volume":"46","author":"LA van Meeteren","year":"2007","unstructured":"van Meeteren LA, Moolenaar WH (2007) Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res 46(2):145\u2013160. https:\/\/doi.org\/10.1016\/j.plipres.2007.02.001","journal-title":"Prog Lipid Res"},{"issue":"1","key":"1719_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbalip.2012.09.013","volume":"1831","author":"WH Moolenaar","year":"2013","unstructured":"Moolenaar WH, Houben AJ, Lee SJ, van Meeteren LA (2013) Autotaxin in embryonic development. Biochim Biophys Acta 1831(1):13\u201319. https:\/\/doi.org\/10.1016\/j.bbalip.2012.09.013","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"1719_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0925-4773(99)00048-9","volume":"84","author":"D Bachner","year":"1999","unstructured":"Bachner D, Ahrens M, Betat N, Schroder D, Gross G (1999) Developmental expression analysis of murine autotaxin (ATX). Mech Dev 84(1\u20132):121\u2013125","journal-title":"Mech Dev"},{"issue":"4","key":"1719_CR28","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/dvdy.21119","volume":"236","author":"H Ohuchi","year":"2007","unstructured":"Ohuchi H, Hayashibara Y, Matsuda H, Onoi M, Mitsumori M, Tanaka M, Aoki J, Arai H et al (2007) Diversified expression patterns of autotaxin, a gene for phospholipid-generating enzyme during mouse and chicken development. Dev Dyn 236(4):1134\u20131143. https:\/\/doi.org\/10.1002\/dvdy.21119","journal-title":"Dev Dyn"},{"issue":"2","key":"1719_CR29","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ydbio.2010.01.007","volume":"339","author":"S Fotopoulou","year":"2010","unstructured":"Fotopoulou S, Oikonomou N, Grigorieva E, Nikitopoulou I, Paparountas T, Thanassopoulou A, Zhao Z, Xu Y et al (2010) ATX expression and LPA signalling are vital for the development of the nervous system. Dev Biol 339(2):451\u2013464. https:\/\/doi.org\/10.1016\/j.ydbio.2010.01.007","journal-title":"Dev Biol"},{"issue":"2","key":"1719_CR30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/dvdy.22543","volume":"240","author":"S Koike","year":"2011","unstructured":"Koike S, Yutoh Y, Keino-Masu K, Noji S, Masu M, Ohuchi H (2011) Autotaxin is required for the cranial neural tube closure and establishment of the midbrain\u2013hindbrain boundary during mouse development. Dev Dyn 240(2):413\u2013421","journal-title":"Dev Dyn"},{"key":"1719_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnins.2015.00053","volume":"9","author":"R Greenman","year":"2015","unstructured":"Greenman R, Gorelik A, Sapir T, Baumgart J, Zamor V, Segal-Salto M, Levin-Zaidman S, Aidinis V et al (2015) Non-cell autonomous and non-catalytic activities of ATX in the developing brain. Front Neurosci 9:53. https:\/\/doi.org\/10.3389\/fnins.2015.00053","journal-title":"Front Neurosci"},{"issue":"4","key":"1719_CR32","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/j.1471-4159.2004.02933.x","volume":"92","author":"K Sato","year":"2005","unstructured":"Sato K, Malchinkhuu E, Muraki T, Ishikawa K, Hayashi K, Tosaka M, Mochiduki A, Inoue K et al (2005) Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources. J Neurochem 92(4):904\u2013914","journal-title":"J Neurochem"},{"issue":"11","key":"1719_CR33","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1073\/pnas.95.11.6151","volume":"95","author":"N Fukushima","year":"1998","unstructured":"Fukushima N, Kimura Y, Chun J (1998) A single receptor encoded by vzg-1\/lpA1\/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proc Natl Acad Sci U S A 95(11):6151\u20136156. https:\/\/doi.org\/10.1073\/pnas.95.11.6151","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1719_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/s0378-1119(01)00410-3","volume":"267","author":"JJ Contos","year":"2001","unstructured":"Contos JJ, Chun J (2001) The mouse lp(A3)\/Edg7 lysophosphatidic acid receptor gene: genomic structure, chromosomal localization, and expression pattern. Gene 267(2):243\u2013253. https:\/\/doi.org\/10.1016\/s0378-1119(01)00410-3","journal-title":"Gene"},{"issue":"7","key":"1719_CR35","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1074\/jbc.M610826200","volume":"282","author":"CW Lee","year":"2007","unstructured":"Lee CW, Rivera R, Dubin AE, Chun J (2007) LPA(4)\/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)\/G(i)-mediated calcium signaling and G(12\/13)-mediated Rho activation. J Biol Chem 282(7):4310\u20134317. https:\/\/doi.org\/10.1074\/jbc.M610826200","journal-title":"J Biol Chem"},{"issue":"12","key":"1719_CR36","doi-asserted-by":"publisher","first-page":"7470","DOI":"10.1074\/jbc.M707758200","volume":"283","author":"TC Spohr","year":"2008","unstructured":"Spohr TC, Choi JW, Gardell SE, Herr DR, Rehen SK, Gomes FC, Chun J (2008) Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation. J Biol Chem 283(12):7470\u20137479. https:\/\/doi.org\/10.1074\/jbc.M707758200","journal-title":"J Biol Chem"},{"issue":"10","key":"1719_CR37","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/glia.22381","volume":"60","author":"LW Yuelling","year":"2012","unstructured":"Yuelling LW, Waggener CT, Afshari FS, Lister JA, Fuss B (2012) Autotaxin\/ENPP2 regulates oligodendrocyte differentiation in vivo in the developing zebrafish hindbrain. Glia 60(10):1605\u20131618. https:\/\/doi.org\/10.1002\/glia.22381","journal-title":"Glia"},{"issue":"32","key":"1719_CR38","doi-asserted-by":"publisher","first-page":"11399","DOI":"10.1523\/JNEUROSCI.0345-15.2015","volume":"35","author":"NA Wheeler","year":"2015","unstructured":"Wheeler NA, Lister JA, Fuss B (2015) The autotaxin\u2013lysophosphatidic acid axis modulates histone acetylation and gene expression during oligodendrocyte differentiation. J Neurosci 35(32):11399\u201311414","journal-title":"J Neurosci"},{"issue":"1","key":"1719_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bbalip.2012.07.015","volume":"1831","author":"JW Choi","year":"2013","unstructured":"Choi JW, Chun J (2013) Lysophospholipids and their receptors in the central nervous system. Biochim Biophys Acta 1831(1):20\u201332. https:\/\/doi.org\/10.1016\/j.bbalip.2012.07.015","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"1719_CR40","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/(SICI)1096-9861(19980907)398:4<587::AID-CNE10>3.0.CO;2-5","volume":"398","author":"JA Weiner","year":"1998","unstructured":"Weiner JA, Hecht JH, Chun J (1998) Lysophosphatidic acid receptor gene vzg-1\/lpA1\/edg-2 is expressed by mature oligodendrocytes during myelination in the postnatal murine brain. J Comp Neurol 398(4):587\u2013598","journal-title":"J Comp Neurol"},{"issue":"6","key":"1719_CR41","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1007\/s00429-014-0885-7","volume":"220","author":"B Garcia-Diaz","year":"2015","unstructured":"Garcia-Diaz B, Riquelme R, Varela-Nieto I, Jimenez AJ, de Diego I, Gomez-Conde AI, Matas-Rico E, Aguirre JA et al (2015) Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex. Brain Struct Funct 220(6):3701\u20133720. https:\/\/doi.org\/10.1007\/s00429-014-0885-7","journal-title":"Brain Struct Funct"},{"issue":"1","key":"1719_CR42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s11064-008-9772-z","volume":"34","author":"L Nogaroli","year":"2009","unstructured":"Nogaroli L, Yuelling LM, Dennis J, Gorse K, Payne SG, Fuss B (2009) Lysophosphatidic acid can support the formation of membranous structures and an increase in MBP mRNA levels in differentiating oligodendrocytes. Neurochem Res 34(1):182\u2013193. https:\/\/doi.org\/10.1007\/s11064-008-9772-z","journal-title":"Neurochem Res"},{"issue":"3","key":"1719_CR43","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S1044-7431(03)00073-3","volume":"23","author":"MA Fox","year":"2003","unstructured":"Fox MA, Colello RJ, Macklin WB, Fuss B (2003) Phosphodiesterase-Ialpha\/autotaxin: a counteradhesive protein expressed by oligodendrocytes during onset of myelination. Mol Cell Neurosci 23(3):507\u2013519","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"1719_CR44","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.mcn.2004.06.002","volume":"27","author":"MA Fox","year":"2004","unstructured":"Fox MA, Alexander JK, Afshari FS, Colello RJ, Fuss B (2004) Phosphodiesterase-I alpha\/autotaxin controls cytoskeletal organization and FAK phosphorylation during myelination. Mol Cell Neurosci 27(2):140\u2013150. https:\/\/doi.org\/10.1016\/j.mcn.2004.06.002","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"1719_CR45","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.mcn.2007.10.018","volume":"37","author":"J Dennis","year":"2008","unstructured":"Dennis J, White MA, Forrest AD, Yuelling LM, Nogaroli L, Afshari FS, Fox MA, Fuss B (2008) Phosphodiesterase-Ialpha\/autotaxin\u2019s MORFO domain regulates oligodendroglial process network formation and focal adhesion organization. Mol Cell Neurosci 37(2):412\u2013424. https:\/\/doi.org\/10.1016\/j.mcn.2007.10.018","journal-title":"Mol Cell Neurosci"},{"issue":"9","key":"1719_CR46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.bbalip.2008.04.009","volume":"1781","author":"LM Yuelling","year":"2008","unstructured":"Yuelling LM, Fuss B (2008) Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties. Biochim Biophys Acta 1781(9):525\u2013530. https:\/\/doi.org\/10.1016\/j.bbalip.2008.04.009","journal-title":"Biochim Biophys Acta"},{"issue":"17","key":"1719_CR47","first-page":"5446","volume":"63","author":"T Clair","year":"2003","unstructured":"Clair T, Aoki J, Koh E, Bandle RW, Nam SW, Ptaszynska MM, Mills GB, Schiffmann E et al (2003) Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res 63(17):5446\u20135453","journal-title":"Cancer Res"},{"issue":"7","key":"1719_CR48","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1096\/fj.06-7420com","volume":"21","author":"AS Novgorodov","year":"2007","unstructured":"Novgorodov AS, El-Alwani M, Bielawski J, Obeid LM, Gudz TI (2007) Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. FASEB J 21(7):1503\u20131514. https:\/\/doi.org\/10.1096\/fj.06-7420com","journal-title":"FASEB J"},{"issue":"8","key":"1719_CR49","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/glia.22688","volume":"62","author":"QL Cui","year":"2014","unstructured":"Cui QL, Fang J, Kennedy TE, Almazan G, Antel JP (2014) Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors. Glia 62(8):1361\u20131375. https:\/\/doi.org\/10.1002\/glia.22688","journal-title":"Glia"},{"issue":"16","key":"1719_CR50","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1002\/glia.20576","volume":"55","author":"CG Jung","year":"2007","unstructured":"Jung CG, Kim HJ, Miron VE, Cook S, Kennedy TE, Foster CA, Antel JP, Soliven B (2007) Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia 55(16):1656\u20131667. https:\/\/doi.org\/10.1002\/glia.20576","journal-title":"Glia"},{"issue":"12","key":"1719_CR51","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1002\/jcb.24889","volume":"115","author":"R Awada","year":"2014","unstructured":"Awada R, Saulnier-Blache JS, Gres S, Bourdon E, Rondeau P, Parimisetty A, Orihuela R, Harry GJ et al (2014) Autotaxin downregulates LPS-induced microglia activation and pro-inflammatory cytokines production. J Cell Biochem 115(12):2123\u20132132. https:\/\/doi.org\/10.1002\/jcb.24889","journal-title":"J Cell Biochem"},{"issue":"2","key":"1719_CR52","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.freeradbiomed.2011.11.014","volume":"52","author":"R Awada","year":"2012","unstructured":"Awada R, Rondeau P, Gres S, Saulnier-Blache JS, Lefebvre d'Hellencourt C, Bourdon E (2012) Autotaxin protects microglial cells against oxidative stress. Free Radic Biol Med 52(2):516\u2013526. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.11.014","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"1719_CR53","doi-asserted-by":"publisher","first-page":"e0133619","DOI":"10.1371\/journal.pone.0133619","volume":"10","author":"MA Mouratis","year":"2015","unstructured":"Mouratis MA, Magkrioti C, Oikonomou N, Katsifa A, Prestwich GD, Kaffe E, Aidinis V (2015) Autotaxin and endotoxin-induced acute lung injury. PLoS One 10(7):e0133619. https:\/\/doi.org\/10.1371\/journal.pone.0133619","journal-title":"PLoS One"},{"issue":"5","key":"1719_CR54","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s10753-017-0612-7","volume":"40","author":"K Mirzoyan","year":"2017","unstructured":"Mirzoyan K, Denis C, Casemayou A, Gilet M, Marsal D, Goudouneche D, Faguer S, Bascands JL et al (2017) Lysophosphatidic acid protects against endotoxin-induced acute kidney injury. Inflammation 40(5):1707\u20131716. https:\/\/doi.org\/10.1007\/s10753-017-0612-7","journal-title":"Inflammation"},{"issue":"7","key":"1719_CR55","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1111\/j.1476-5381.2010.00828.x","volume":"160","author":"JS Swaney","year":"2010","unstructured":"Swaney JS, Chapman C, Correa LD, Stebbins KJ, Bundey RA, Prodanovich PC, Fagan P, Baccei CS et al (2010) A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. Br J Pharmacol 160(7):1699\u20131713. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00828.x","journal-title":"Br J Pharmacol"},{"issue":"5","key":"1719_CR56","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/glia.23585","volume":"67","author":"JW Robering","year":"2019","unstructured":"Robering JW, Gebhardt L, Wolf K, Kuhn H, Kremer AE, Fischer MJM (2019) Lysophosphatidic acid activates satellite glia cells and Schwann cells. Glia 67(5):999\u20131012. https:\/\/doi.org\/10.1002\/glia.23585","journal-title":"Glia"},{"issue":"2","key":"1719_CR57","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.neuint.2006.09.003","volume":"50","author":"R Fujita","year":"2007","unstructured":"Fujita R, Kiguchi N, Ueda H (2007) LPA-mediated demyelination in ex vivo culture of dorsal root. Neurochem Int 50(2):351\u2013355. https:\/\/doi.org\/10.1016\/j.neuint.2006.09.003","journal-title":"Neurochem Int"},{"issue":"2","key":"1719_CR58","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jphs.2016.07.010","volume":"132","author":"R Tsukahara","year":"2016","unstructured":"Tsukahara R, Ueda H (2016) Myelin-related gene silencing mediated by LPA1 - Rho\/ROCK signaling is correlated to acetylation of NFkappaB in S16 Schwann cells. J Pharmacol Sci 132(2):162\u2013165. https:\/\/doi.org\/10.1016\/j.jphs.2016.07.010","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"1719_CR59","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuroscience.2007.12.041","volume":"152","author":"M Inoue","year":"2008","unstructured":"Inoue M, Xie W, Matsushita Y, Chun J, Aoki J, Ueda H (2008) Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid. Neuroscience 152(2):296\u2013298. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.12.041","journal-title":"Neuroscience"},{"issue":"1","key":"1719_CR60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbalip.2012.08.014","volume":"1831","author":"H Ueda","year":"2013","unstructured":"Ueda H, Matsunaga H, Olaposi OI, Nagai J (2013) Lysophosphatidic acid: chemical signature of neuropathic pain. Biochim Biophys Acta 1831(1):61\u201373. https:\/\/doi.org\/10.1016\/j.bbalip.2012.08.014","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"1719_CR61","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.4049\/jimmunol.1500733","volume":"195","author":"S McArthur","year":"2015","unstructured":"McArthur S, Gobbetti T, Kusters DH, Reutelingsperger CP, Flower RJ, Perretti M (2015) Definition of a novel pathway centered on lysophosphatidic acid to recruit monocytes during the resolution phase of tissue inflammation. J Immunol 195(3):1139\u20131151. https:\/\/doi.org\/10.4049\/jimmunol.1500733","journal-title":"J Immunol"},{"issue":"6","key":"1719_CR62","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jocn.2014.02.013","volume":"21","author":"Wayne Ng","year":"2014","unstructured":"Ng W, P\u00e9bay A, Drummond K, Burgess A, Kaye AH, Morokoff A (2014) Complexities of lysophospholipid signalling in glioblastoma. 21. https:\/\/doi.org\/10.1016\/j.jocn.2014.02.013","journal-title":"Journal of Clinical Neuroscience"},{"issue":"9","key":"1719_CR63","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1182\/blood-2016-10-743757","volume":"129","author":"Rashmi Ray","year":"2017","unstructured":"Ray R, Rai V (2017) Lysophosphatidic acid converts monocytes into macrophages in both mice and humans. Blood. 2017 Mar 2;129(9):1177-1183. https:\/\/doi.org\/10.1182\/blood-2016-10-743757 .","journal-title":"Blood"},{"issue":"5","key":"1719_CR64","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1023\/A:1007542532395","volume":"25","author":"S Tabuchi","year":"2000","unstructured":"Tabuchi S, Kume K, Aihara M, Shimizu T (2000) Expression of lysophosphatidic acid receptor in rat astrocytes: mitogenic effect and expression of neurotrophic genes. Neurochem Res 25(5):573\u2013582. https:\/\/doi.org\/10.1023\/A:1007542532395","journal-title":"Neurochem Res"},{"issue":"8","key":"1719_CR65","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.115.016757","volume":"132","author":"R Bouchareb","year":"2015","unstructured":"Bouchareb R, Mahmut A, Nsaibia MJ, Boulanger MC, Dahou A, Lepine JL, Laflamme MH, Hadji F et al (2015) Autotaxin derived from lipoprotein(a) and valve interstitial cells promotes inflammation and mineralization of the aortic valve. Circulation 132(8):677\u2013690. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016757","journal-title":"Circulation"},{"issue":"8","key":"1719_CR66","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1164\/rccm.201306-1014OC","volume":"188","author":"GY Park","year":"2013","unstructured":"Park GY, Lee YG, Berdyshev E, Nyenhuis S, Du J, Fu P, Gorshkova IA, Li Y et al (2013) Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation. Am J Respir Crit Care Med 188(8):928\u2013940. https:\/\/doi.org\/10.1164\/rccm.201306-1014OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"1719_CR67","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/carcin\/bgx100","volume":"38","author":"H Zheng","year":"2017","unstructured":"Zheng H, Hogberg J, Stenius U (2017) ATM-activated autotaxin (ATX) propagates inflammation and DNA damage in lung epithelial cells: a new mode of action for silica-induced DNA damage? Carcinogenesis 38(12):1196\u20131206. https:\/\/doi.org\/10.1093\/carcin\/bgx100","journal-title":"Carcinogenesis"},{"issue":"6","key":"1719_CR68","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/01.mcg.0000225642.90898.0e","volume":"41","author":"N Watanabe","year":"2007","unstructured":"Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Aoki J, Hama K, Okudaira S et al (2007) Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J Clin Gastroenterol 41(6):616\u2013623. https:\/\/doi.org\/10.1097\/01.mcg.0000225642.90898.0e","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"1719_CR69","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.febslet.2012.01.044","volume":"586","author":"S Li","year":"2012","unstructured":"Li S, Xiong C, Zhang J (2012) ATX and LPA receptor 3 are coordinately up-regulated in lipopolysaccharide-stimulated THP-1 cells through PKR and SPK1-mediated pathways. FEBS Lett 586(6):792\u2013797. https:\/\/doi.org\/10.1016\/j.febslet.2012.01.044","journal-title":"FEBS Lett"},{"issue":"2","key":"1719_CR70","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bbrc.2008.11.047","volume":"378","author":"S Li","year":"2009","unstructured":"Li S, Zhang J (2009) Lipopolysaccharide induces autotaxin expression in human monocytic THP-1 cells. Biochem Biophys Res Commun 378(2):264\u2013268. https:\/\/doi.org\/10.1016\/j.bbrc.2008.11.047","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1719_CR71","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.2353\/ajpath.2008.071153","volume":"173","author":"T Nakasaki","year":"2008","unstructured":"Nakasaki T, Tanaka T, Okudaira S, Hirosawa M, Umemoto E, Otani K, Jin S, Bai Z et al (2008) Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions. Am J Pathol 173(5):1566\u20131576. https:\/\/doi.org\/10.2353\/ajpath.2008.071153","journal-title":"Am J Pathol"},{"issue":"4","key":"1719_CR72","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1530\/ERC-15-0045","volume":"22","author":"MG Benesch","year":"2015","unstructured":"Benesch MG, Ko YM, Tang X, Dewald J, Lopez-Campistrous A, Zhao YY, Lai R, Curtis JM et al (2015) Autotaxin is an inflammatory mediator and therapeutic target in thyroid cancer. Endocr Relat Cancer 22(4):593\u2013607. https:\/\/doi.org\/10.1530\/ERC-15-0045","journal-title":"Endocr Relat Cancer"},{"key":"1719_CR73","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1476-4598-9-71","volume":"9","author":"JM Wu","year":"2010","unstructured":"Wu JM, Xu Y, Skill NJ, Sheng H, Zhao Z, Yu M, Saxena R, Maluccio MA (2010) Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma. Mol Cancer 9:71. https:\/\/doi.org\/10.1186\/1476-4598-9-71","journal-title":"Mol Cancer"},{"issue":"9","key":"1719_CR74","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1096\/fj.15-274480","volume":"29","author":"MG Benesch","year":"2015","unstructured":"Benesch MG, Tang X, Dewald J, Dong WF, Mackey JR, Hemmings DG, McMullen TP, Brindley DN (2015) Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression. FASEB J 29(9):3990\u20134000. https:\/\/doi.org\/10.1096\/fj.15-274480","journal-title":"FASEB J"},{"issue":"1","key":"1719_CR75","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bbalip.2012.08.015","volume":"1831","author":"DN Brindley","year":"2013","unstructured":"Brindley DN, Lin FT, Tigyi GJ (2013) Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy. Biochim Biophys Acta 1831(1):74\u201385. https:\/\/doi.org\/10.1016\/j.bbalip.2012.08.015","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1719_CR76","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.yexcr.2014.11.010","volume":"333","author":"R Leblanc","year":"2015","unstructured":"Leblanc R, Peyruchaud O (2015) New insights into the autotaxin\/LPA axis in cancer development and metastasis. Exp Cell Res 333(2):183\u2013189. https:\/\/doi.org\/10.1016\/j.yexcr.2014.11.010","journal-title":"Exp Cell Res"},{"issue":"2","key":"1719_CR77","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1083\/jcb.200204026","volume":"158","author":"M Umezu-Goto","year":"2002","unstructured":"Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB et al (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158(2):227\u2013233. https:\/\/doi.org\/10.1083\/jcb.200204026","journal-title":"J Cell Biol"},{"issue":"16","key":"1719_CR78","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.febslet.2014.02.009","volume":"588","author":"Matthew G.K. Benesch","year":"2014","unstructured":"Benesch MGK, Ko YM, McMullen TPW, Brindley DN (2014) Autotaxin in the crosshairs: Taking aim at cancer and other inflammatory conditions. 588. https:\/\/doi.org\/10.1016\/j.febslet.2014.02.009","journal-title":"FEBS Letters"},{"issue":"6","key":"1719_CR79","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ccr.2009.03.027","volume":"15","author":"S Liu","year":"2009","unstructured":"Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, Zhang F, Yu S, Stephens LC et al (2009) Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell 15(6):539\u2013550. https:\/\/doi.org\/10.1016\/j.ccr.2009.03.027","journal-title":"Cancer Cell"},{"issue":"2","key":"1719_CR80","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ardp.201200395","volume":"346","author":"PD St-Coeur","year":"2013","unstructured":"St-Coeur PD, Ferguson D, Morin P Jr, Touaibia M (2013) PF-8380 and closely related analogs: synthesis and structure-activity relationship towards autotaxin inhibition and glioma cell viability. Arch Pharm (Weinheim) 346(2):91\u201397. https:\/\/doi.org\/10.1002\/ardp.201200395","journal-title":"Arch Pharm (Weinheim)"},{"issue":"3","key":"1719_CR81","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11060-007-9480-6","volume":"86","author":"DB Hoelzinger","year":"2008","unstructured":"Hoelzinger DB, Nakada M, Demuth T, Rosensteel T, Reavie LB, Berens ME (2008) Autotaxin: a secreted autocrine\/paracrine factor that promotes glioma invasion. J Neuro-Oncol 86(3):297\u2013309. https:\/\/doi.org\/10.1007\/s11060-007-9480-6","journal-title":"J Neuro-Oncol"},{"issue":"25","key":"1719_CR82","doi-asserted-by":"publisher","first-page":"17492","DOI":"10.1074\/jbc.M601803200","volume":"281","author":"Y Kishi","year":"2006","unstructured":"Kishi Y, Okudaira S, Tanaka M, Hama K, Shida D, Kitayama J, Yamori T, Aoki J et al (2006) Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J Biol Chem 281(25):17492\u201317500","journal-title":"J Biol Chem"},{"issue":"12","key":"1719_CR83","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/oby.21232","volume":"23","author":"VL Reeves","year":"2015","unstructured":"Reeves VL, Trybula JS, Wills RC, Goodpaster BH, Dub\u00e9 JJ, Kienesberger PC, Kershaw EE (2015) Serum autotaxin\/ENPP 2 correlates with insulin resistance in older humans with obesity. Obesity 23(12):2371\u20132376","journal-title":"Obesity"},{"issue":"1","key":"1719_CR84","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12974-016-0530-x","volume":"13","author":"A Parimisetty","year":"2016","unstructured":"Parimisetty A, Dorsemans AC, Awada R, Ravanan P, Diotel N, Lefebvre d\u2019Hellencourt C (2016) Secret talk between adipose tissue and central nervous system via secreted factors\u2014an emerging frontier in the neurodegenerative research. J Neuroinflammation 13(1):67. https:\/\/doi.org\/10.1186\/s12974-016-0530-x","journal-title":"J Neuroinflammation"},{"issue":"2","key":"1719_CR85","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-2275(20)30173-5","volume":"43","author":"A Tokumura","year":"2002","unstructured":"Tokumura A, Kanaya Y, Kitahara M, Miyake M, Yoshioka Y, Fukuzawa K (2002) Increased formation of lysophosphatidic acids by lysophospholipase D in serum of hypercholesterolemic rabbits. J Lipid Res 43(2):307\u2013315","journal-title":"J Lipid Res"},{"issue":"5","key":"1719_CR86","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1210\/me.2011-1229","volume":"26","author":"L Federico","year":"2012","unstructured":"Federico L, Ren H, Mueller PA, Wu T, Liu S, Popovic J, Blalock EM, Sunkara M et al (2012) Autotaxin and its product lysophosphatidic acid suppress brown adipose differentiation and promote diet-induced obesity in mice. Mol Endocrinol 26(5):786\u2013797. https:\/\/doi.org\/10.1210\/me.2011-1229","journal-title":"Mol Endocrinol"},{"issue":"12","key":"1719_CR87","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.2337\/db13-1694","volume":"63","author":"S Nishimura","year":"2014","unstructured":"Nishimura S, Nagasaki M, Okudaira S, Aoki J, Ohmori T, Ohkawa R, Nakamura K, Igarashi K et al (2014) ENPP2 contributes to adipose tissue expansion and insulin resistance in diet-induced obesity. Diabetes 63(12):4154\u20134164. https:\/\/doi.org\/10.2337\/db13-1694","journal-title":"Diabetes"},{"issue":"2","key":"1719_CR88","doi-asserted-by":"publisher","first-page":"e0171664","DOI":"10.1371\/journal.pone.0171664","volume":"12","author":"SE Kim","year":"2017","unstructured":"Kim SE, Choo J, Yoon J, Chu JR, Bae YJ, Lee S, Park T, Sung MK (2017) Genome-wide analysis identifies colonic genes differentially associated with serum leptin and insulin concentrations in C57BL\/6J mice fed a high-fat diet. PLoS One 12(2):e0171664. https:\/\/doi.org\/10.1371\/journal.pone.0171664","journal-title":"PLoS One"},{"issue":"18","key":"1719_CR89","first-page":"6938","volume":"61","author":"SW Nam","year":"2001","unstructured":"Nam SW, Clair T, Kim Y-S, McMarlin A, Schiffmann E, Liotta LA, Stracke ML (2001) Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res 61(18):6938\u20136944","journal-title":"Cancer Res"},{"issue":"3","key":"1719_CR90","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1158\/1541-7786.MCR-09-0288","volume":"8","author":"M. M. Ptaszynska","year":"2010","unstructured":"Ptaszynska MM, Pendrak ML, Stracke ML, Roberts DD (2010) Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor\u2013induced endothelial cell migration. Mol Cancer Res. 2010 Mar;8(3):309-21. https:\/\/doi.org\/10.1158\/1541-7786.MCR-09-0288 .","journal-title":"Molecular Cancer Research"},{"issue":"5","key":"1719_CR91","doi-asserted-by":"publisher","first-page":"e0126734","DOI":"10.1371\/journal.pone.0126734","volume":"10","author":"H Yukiura","year":"2015","unstructured":"Yukiura H, Kano K, Kise R, Inoue A, Aoki J (2015) Autotaxin overexpression causes embryonic lethality and vascular defects. PLoS One 10(5):e0126734. https:\/\/doi.org\/10.1371\/journal.pone.0126734","journal-title":"PLoS One"},{"issue":"10","key":"1719_CR92","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1128\/MCB.01275-09","volume":"30","author":"E Im","year":"2010","unstructured":"Im E, Motiejunaite R, Aranda J, Park EY, Federico L, Kim TI, Clair T, Stracke ML et al (2010) Phospholipase Cgamma activation drives increased production of autotaxin in endothelial cells and lysophosphatidic acid-dependent regression. Mol Cell Biol 30(10):2401\u20132410. https:\/\/doi.org\/10.1128\/MCB.01275-09","journal-title":"Mol Cell Biol"},{"key":"1719_CR93","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mvr.2014.03.003","volume":"93","author":"R Motiej\u016bnait\u0117","year":"2014","unstructured":"Motiej\u016bnait\u0117 R, Aranda J, Kazlauskas A (2014) Pericytes prevent regression of endothelial cell tubes by accelerating metabolism of lysophosphatidic acid. Microvasc Res 93:62\u201371","journal-title":"Microvasc Res"},{"issue":"11","key":"1719_CR94","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1194\/jlr.M009449","volume":"51","author":"O Quehenberger","year":"2010","unstructured":"Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH, Bandyopadhyay S, Jones KN et al (2010) Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res 51(11):3299\u20133305. https:\/\/doi.org\/10.1194\/jlr.M009449","journal-title":"J Lipid Res"},{"issue":"5","key":"1719_CR95","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1471-4159.1971.tb12006.x","volume":"18","author":"DR Illingworth","year":"1971","unstructured":"Illingworth DR, Glover J (1971) The composition of lipids in cerebrospinal fluid of children and adults. J Neurochem 18(5):769\u2013776. https:\/\/doi.org\/10.1111\/j.1471-4159.1971.tb12006.x","journal-title":"J Neurochem"},{"issue":"7","key":"1719_CR96","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nm1060","volume":"10","author":"M Inoue","year":"2004","unstructured":"Inoue M, Rashid MH, Fujita R, Contos JJ, Chun J, Ueda H (2004) Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 10(7):712\u2013718. https:\/\/doi.org\/10.1038\/nm1060","journal-title":"Nat Med"},{"issue":"1\u20132","key":"1719_CR97","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pharmthera.2005.06.003","volume":"109","author":"H Ueda","year":"2006","unstructured":"Ueda H (2006) Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. Pharmacol Ther 109(1\u20132):57\u201377. https:\/\/doi.org\/10.1016\/j.pharmthera.2005.06.003","journal-title":"Pharmacol Ther"},{"issue":"11","key":"1719_CR98","doi-asserted-by":"publisher","first-page":"e0207310","DOI":"10.1371\/journal.pone.0207310","volume":"13","author":"K Kuwajima","year":"2018","unstructured":"Kuwajima K, Sumitani M, Kurano M, Kano K, Nishikawa M, Uranbileg B, Tsuchida R, Ogata T et al (2018) Lysophosphatidic acid is associated with neuropathic pain intensity in humans: an exploratory study. PLoS One 13(11):e0207310. https:\/\/doi.org\/10.1371\/journal.pone.0207310","journal-title":"PLoS One"},{"key":"1719_CR99","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1744-8069-6-78","volume":"6","author":"J Nagai","year":"2010","unstructured":"Nagai J, Uchida H, Matsushita Y, Yano R, Ueda M, Niwa M, Aoki J, Chun J et al (2010) Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine. Mol Pain 6:78. https:\/\/doi.org\/10.1186\/1744-8069-6-78","journal-title":"Mol Pain"},{"issue":"1","key":"1719_CR100","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1744-8069-4-6","volume":"4","author":"M Inoue","year":"2008","unstructured":"Inoue M, Ma L, Aoki J, Chun J, Ueda H (2008) Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Mol Pain 4(1):6. https:\/\/doi.org\/10.1186\/1744-8069-4-6","journal-title":"Mol Pain"},{"issue":"2","key":"1719_CR101","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1471-4159.2011.07297.x","volume":"118","author":"J Nagai","year":"2011","unstructured":"Nagai J, Ueda H (2011) Pre-emptive morphine treatment abolishes nerve injury-induced lysophospholipid synthesis in mass spectrometrical analysis. J Neurochem 118(2):256\u2013265. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07297.x","journal-title":"J Neurochem"},{"key":"1719_CR102","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1744-8069-5-64","volume":"5","author":"L Ma","year":"2009","unstructured":"Ma L, Uchida H, Nagai J, Inoue M, Chun J, Aoki J, Ueda H (2009) Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain. Mol Pain 5:64. https:\/\/doi.org\/10.1186\/1744-8069-5-64","journal-title":"Mol Pain"},{"issue":"Pt B","key":"1719_CR103","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuropharm.2016.04.002","volume":"113","author":"M Velasco","year":"2017","unstructured":"Velasco M, O'Sullivan C, Sheridan GK (2017) Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain. Neuropharmacology 113(Pt B):608\u2013617. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.04.002","journal-title":"Neuropharmacology"},{"issue":"1","key":"1719_CR104","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.sjpain.2015.04.021","volume":"8","author":"J Su","year":"2015","unstructured":"Su J, Delaney A, Matteo R, Bartlett B, Kultima K, H\u00f6kfelt T, Svensson C (2015) Blockage of lysophosphatidic acid reverses arthritis-induced hypersensitivity and Cav\u03b12\u03b41 and P2X3 expression in dorsal root ganglia. Scand J Pain 8(1):53\u201354","journal-title":"Scand J Pain"},{"key":"1719_CR105","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejphar.2018.10.005","volume":"841","author":"M Srikanth","year":"2018","unstructured":"Srikanth M, Chew WS, Hind T, Lim SM, Hay NWJ, Lee JHM, Rivera R, Chun J et al (2018) Lysophosphatidic acid and its receptor LPA1 mediate carrageenan induced inflammatory pain in mice. Eur J Pharmacol 841:49\u201356. https:\/\/doi.org\/10.1016\/j.ejphar.2018.10.005","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"1719_CR106","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/j.1471-4159.2008.05725.x","volume":"107","author":"M Inoue","year":"2008","unstructured":"Inoue M, Ma L, Aoki J, Ueda H (2008) Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain. J Neurochem 107(6):1556\u20131565. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05725.x","journal-title":"J Neurochem"},{"issue":"2","key":"1719_CR107","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1124\/jpet.109.164830","volume":"333","author":"L Ma","year":"2010","unstructured":"Ma L, Uchida H, Nagai J, Inoue M, Aoki J, Ueda H (2010) Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain. J Pharmacol Exp Ther 333(2):540\u2013546. https:\/\/doi.org\/10.1124\/jpet.109.164830","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"1719_CR108","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pain.2004.08.009","volume":"112","author":"JF Yeo","year":"2004","unstructured":"Yeo JF, Ong WY, Ling SF, Farooqui AA (2004) Intracerebroventricular injection of phospholipases A2 inhibitors modulates allodynia after facial carrageenan injection in mice. Pain 112(1\u20132):148\u2013155. https:\/\/doi.org\/10.1016\/j.pain.2004.08.009","journal-title":"Pain"},{"key":"1719_CR109","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1744-8069-7-33","volume":"7","author":"Y Kakiuchi","year":"2011","unstructured":"Kakiuchi Y, Nagai J, Gotoh M, Hotta H, Murofushi H, Ogawa T, Ueda H, Murakami-Murofushi K (2011) Antinociceptive effect of cyclic phosphatidic acid and its derivative on animal models of acute and chronic pain. Mol Pain 7:33. https:\/\/doi.org\/10.1186\/1744-8069-7-33","journal-title":"Mol Pain"},{"issue":"9","key":"1719_CR110","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1021\/acsmedchemlett.6b00207","volume":"7","author":"SB Jones","year":"2016","unstructured":"Jones SB, Pfeifer LA, Bleisch TJ, Beauchamp TJ, Durbin JD, Klimkowski VJ, Hughes NE, Rito CJ et al (2016) Novel autotaxin inhibitors for the treatment of osteoarthritis pain: lead optimization via structure-based drug design. ACS Med Chem Lett 7(9):857\u2013861. https:\/\/doi.org\/10.1021\/acsmedchemlett.6b00207","journal-title":"ACS Med Chem Lett"},{"issue":"6","key":"1719_CR111","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.joca.2016.09.006","volume":"25","author":"K Thirunavukkarasu","year":"2017","unstructured":"Thirunavukkarasu K, Swearingen CA, Oskins JL, Lin C, Bui HH, Jones SB, Pfeifer LA, Norman BH et al (2017) Identification and pharmacological characterization of a novel inhibitor of autotaxin in rodent models of joint pain. Osteoarthr Cartil 25(6):935\u2013942. https:\/\/doi.org\/10.1016\/j.joca.2016.09.006","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"1719_CR112","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1124\/jpet.110.165845","volume":"334","author":"J Gierse","year":"2010","unstructured":"Gierse J, Thorarensen A, Beltey K, Bradshaw-Pierce E, Cortes-Burgos L, Hall T, Johnston A, Murphy M et al (2010) A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation. J Pharmacol Exp Ther 334(1):310\u2013317. https:\/\/doi.org\/10.1124\/jpet.110.165845","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"1719_CR113","first-page":"2516","volume":"57","author":"H Kawagoe","year":"1997","unstructured":"Kawagoe H, Stracke ML, Nakamura H, Sano K (1997) Expression and transcriptional regulation of the PD-Ialpha\/autotaxin gene in neuroblastoma. Cancer Res 57(12):2516\u20132521","journal-title":"Cancer Res"},{"issue":"8","key":"1719_CR114","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/cmi.2017.159","volume":"15","author":"M Yao","year":"2018","unstructured":"Yao M, Li S, Wu X, Diao S, Zhang G, He H, Bian L, Lu Y (2018) Cellular origin of glioblastoma and its implication in precision therapy. Cell Mol Immunol 15(8):737\u2013739. https:\/\/doi.org\/10.1038\/cmi.2017.159","journal-title":"Cell Mol Immunol"},{"key":"1719_CR115","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12944-015-0059-5","volume":"14","author":"S Tabuchi","year":"2015","unstructured":"Tabuchi S (2015) The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme. Lipids Health Dis 14:56. https:\/\/doi.org\/10.1186\/s12944-015-0059-5","journal-title":"Lipids Health Dis"},{"issue":"1","key":"1719_CR116","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1593\/neo.04535","volume":"7","author":"DB Hoelzinger","year":"2005","unstructured":"Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS, Sloan A, Coons SW et al (2005) Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7(1):7\u201316. https:\/\/doi.org\/10.1593\/neo.04535","journal-title":"Neoplasia"},{"issue":"10","key":"1719_CR117","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/mc.20541","volume":"48","author":"B Annabi","year":"2009","unstructured":"Annabi B, Lachambre MP, Plouffe K, Sartelet H, Beliveau R (2009) Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. Mol Carcinog 48(10):910\u2013919. https:\/\/doi.org\/10.1002\/mc.20541","journal-title":"Mol Carcinog"},{"issue":"2","key":"1719_CR118","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/0004563218818197","volume":"56","author":"T Shimura","year":"2019","unstructured":"Shimura T, Kurano M, Morita Y, Yoshikawa N, Nishikawa M, Igarashi K, Shimamoto S, Aoki J et al (2019) Autotaxin and soluble IL-2 receptor concentrations in cerebrospinal fluids are useful for the diagnosis of central nervous system invasion caused by haematological malignancies. Ann Clin Biochem 56(2):240\u2013246. https:\/\/doi.org\/10.1177\/0004563218818197","journal-title":"Ann Clin Biochem"},{"key":"1719_CR119","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fonc.2013.00236","volume":"3","author":"SR Bhave","year":"2013","unstructured":"Bhave SR, Dadey DY, Karvas RM, Ferraro DJ, Kotipatruni RP, Jaboin JJ, Hallahan AN, Dewees TA et al (2013) Autotaxin inhibition with PF-8380 enhances the radiosensitivity of human and murine glioblastoma cell lines. Front Oncol 3:236. https:\/\/doi.org\/10.3389\/fonc.2013.00236","journal-title":"Front Oncol"},{"issue":"7","key":"1719_CR120","doi-asserted-by":"publisher","first-page":"e22182","DOI":"10.1371\/journal.pone.0022182","volume":"6","author":"SM Schleicher","year":"2011","unstructured":"Schleicher SM, Thotala DK, Linkous AG, Hu R, Leahy KM, Yazlovitskaya EM, Hallahan DE (2011) Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature. PLoS One 6(7):e22182. https:\/\/doi.org\/10.1371\/journal.pone.0022182","journal-title":"PLoS One"},{"issue":"1","key":"1719_CR121","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1542\/peds.2013-0372","volume":"133","author":"S Bolisetty","year":"2014","unstructured":"Bolisetty S, Dhawan A, Abdel-Latif M, Bajuk B, Stack J, Lui K, New South W, Australian Capital Territory Neonatal Intensive Care Units\u2019 Data C (2014) Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants. Pediatrics 133(1):55\u201362. https:\/\/doi.org\/10.1542\/peds.2013-0372","journal-title":"Pediatrics"},{"key":"1719_CR122","doi-asserted-by":"publisher","first-page":"e541","DOI":"10.1038\/tp.2015.33","volume":"5","author":"H Mirendil","year":"2015","unstructured":"Mirendil H, Thomas EA, De Loera C, Okada K, Inomata Y, Chun J (2015) LPA signaling initiates schizophrenia-like brain and behavioral changes in a mouse model of prenatal brain hemorrhage. Transl Psychiatry 5:e541. https:\/\/doi.org\/10.1038\/tp.2015.33","journal-title":"Transl Psychiatry"},{"issue":"99","key":"1719_CR123","doi-asserted-by":"publisher","first-page":"99ra87","DOI":"10.1126\/scitranslmed.3002095","volume":"3","author":"YC Yung","year":"2011","unstructured":"Yung YC, Mutoh T, Lin ME, Noguchi K, Rivera RR, Choi JW, Kingsbury MA, Chun J (2011) Lysophosphatidic acid signaling may initiate fetal hydrocephalus. Sci Transl Med 3(99):99ra87. https:\/\/doi.org\/10.1126\/scitranslmed.3002095","journal-title":"Sci Transl Med"},{"key":"1719_CR124","doi-asserted-by":"publisher","first-page":"10329","DOI":"10.1038\/ncomms10329","volume":"7","author":"R Park","year":"2016","unstructured":"Park R, Moon UY, Park JY, Hughes LJ, Johnson RL, Cho SH, Kim S (2016) Yap is required for ependymal integrity and is suppressed in LPA-induced hydrocephalus. Nat Commun 7:10329. https:\/\/doi.org\/10.1038\/ncomms10329","journal-title":"Nat Commun"},{"issue":"37","key":"1719_CR125","doi-asserted-by":"publisher","first-page":"15444","DOI":"10.1073\/pnas.1106129108","volume":"108","author":"KJ Herr","year":"2011","unstructured":"Herr KJ, Herr DR, Lee CW, Noguchi K, Chun J (2011) Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling. Proc Natl Acad Sci U S A 108(37):15444\u201315449. https:\/\/doi.org\/10.1073\/pnas.1106129108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"1719_CR126","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/rcm.4620","volume":"24","author":"HY Wang","year":"2010","unstructured":"Wang HY, Liu CB, Wu HW, Kuo JS (2010) Direct profiling of phospholipids and lysophospholipids in rat brain sections after ischemic stroke. Rapid Commun Mass Spectrom 24(14):2057\u20132064. https:\/\/doi.org\/10.1002\/rcm.4620","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"1","key":"1719_CR127","doi-asserted-by":"publisher","first-page":"25","DOI":"10.15252\/emmm.201505677","volume":"8","author":"Johannes Vogt","year":"2015","unstructured":"Vogt J, Yang JW, Mobascher A, Cheng J, Li Y, Liu X, Baumgart J, Thalman C et al (2015) Molecular cause and functional impact of altered synaptic lipid signaling due to a prg-1 gene SNP. EMBO Mol Med. 2016 Jan 1;8(1):25-38. https:\/\/doi.org\/10.15252\/emmm.201505677 .","journal-title":"EMBO Molecular Medicine"},{"issue":"3","key":"1719_CR128","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1191\/1352458504ms1023oa","volume":"10","author":"BN Hammack","year":"2004","unstructured":"Hammack BN, Fung KY, Hunsucker SW, Duncan MW, Burgoon MP, Owens GP, Gilden DH (2004) Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult Scler 10(3):245\u2013260. https:\/\/doi.org\/10.1191\/1352458504ms1023oa","journal-title":"Mult Scler"},{"issue":"1\u20132","key":"1719_CR129","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jneuroim.2014.06.006","volume":"273","author":"H Zahednasab","year":"2014","unstructured":"Zahednasab H, Balood M, Harirchian MH, Mesbah-Namin SA, Rahimian N, Siroos B (2014) Increased autotaxin activity in multiple sclerosis. J Neuroimmunol 273(1\u20132):120\u2013123. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.06.006","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1719_CR130","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-017-0446-4","volume":"5","author":"K Schmitz","year":"2017","unstructured":"Schmitz K, Brunkhorst R, de Bruin N, Mayer CA, Haussler A, Ferreiros N, Schiffmann S, Parnham MJ et al (2017) Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis. Acta Neuropathol Commun 5(1):42. https:\/\/doi.org\/10.1186\/s40478-017-0446-4","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1719_CR131","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1124\/jpet.116.234013","volume":"359","author":"K Thirunavukkarasu","year":"2016","unstructured":"Thirunavukkarasu K, Tan B, Swearingen CA, Rocha G, Bui HH, McCann DJ, Jones SB, Norman BH et al (2016) Pharmacological characterization of a potent inhibitor of autotaxin in animal models of inflammatory bowel disease and multiple sclerosis. J Pharmacol Exp Ther 359(1):207\u2013214. https:\/\/doi.org\/10.1124\/jpet.116.234013","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"1719_CR132","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3390\/ijms19071827","volume":"19","author":"Sindhu Ramesh","year":"2018","unstructured":"Ramesh S, Govindarajulu M, Suppiramaniam V, Moore T, Dhanasekaran M (2018) Autotaxin\u2013lysophosphatidic acid signaling in Alzheimer\u2019s disease. 19. https:\/\/doi.org\/10.3390\/ijms19071827","journal-title":"International Journal of Molecular Sciences"},{"issue":"1\u20132","key":"1719_CR133","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2006.02.008","volume":"400","author":"K Umemura","year":"2006","unstructured":"Umemura K, Yamashita N, Yu X, Arima K, Asada T, Makifuchi T, Murayama S, Saito Y et al (2006) Autotaxin expression is enhanced in frontal cortex of Alzheimer-type dementia patients. Neurosci Lett 400(1\u20132):97\u2013100. https:\/\/doi.org\/10.1016\/j.neulet.2006.02.008","journal-title":"Neurosci Lett"},{"issue":"1","key":"1719_CR134","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3233\/JAD-160891","volume":"56","author":"KE McLimans","year":"2017","unstructured":"McLimans KE, Willette AA, Alzheimer\u2019s disease neuroimaging I (2017) Autotaxin is related to metabolic dysfunction and predicts Alzheimer\u2019s disease outcomes. J Alzheimers Dis 56(1):403\u2013413. https:\/\/doi.org\/10.3233\/JAD-160891","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"1719_CR135","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00702-003-0007-9","volume":"110","author":"C Mulder","year":"2003","unstructured":"Mulder C, Wahlund LO, Teerlink T, Blomberg M, Veerhuis R, van Kamp GJ, Scheltens P, Scheffer PG (2003) Decreased lysophosphatidylcholine\/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer\u2019s disease. J Neural Transm (Vienna) 110(8):949\u2013955. https:\/\/doi.org\/10.1007\/s00702-003-0007-9","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"1719_CR136","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000071001","volume":"16","author":"YX Sun","year":"2003","unstructured":"Sun YX, Minthon L, Wallmark A, Warkentin S, Blennow K, Janciauskiene S (2003) Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 16(3):136\u2013144. https:\/\/doi.org\/10.1159\/000071001","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"12","key":"1719_CR137","doi-asserted-by":"publisher","first-page":"6931","DOI":"10.1073\/pnas.96.12.6931","volume":"96","author":"W Siess","year":"1999","unstructured":"Siess W, Zangl KJ, Essler M, Bauer M, Brandl R, Corrinth C, Bittman R, Tigyi G et al (1999) Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci U S A 96(12):6931\u20136936. https:\/\/doi.org\/10.1073\/pnas.96.12.6931","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1719_CR138","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-49931-4","volume-title":"Glycerophospholipids in the brain","author":"AA Farooqui","year":"2007","unstructured":"Farooqui AA, Horrocks LA (2007) Glycerophospholipids in the brain. https:\/\/doi.org\/10.1007\/978-0-387-49931-4"},{"issue":"1","key":"1719_CR139","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbadis.2012.09.010","volume":"1832","author":"J Shi","year":"2013","unstructured":"Shi J, Dong Y, Cui MZ, Xu X (2013) Lysophosphatidic acid induces increased BACE1 expression and abeta formation. Biochim Biophys Acta 1832(1):29\u201338. https:\/\/doi.org\/10.1016\/j.bbadis.2012.09.010","journal-title":"Biochim Biophys Acta"},{"issue":"52","key":"1719_CR140","doi-asserted-by":"publisher","first-page":"37046","DOI":"10.1074\/jbc.274.52.37046","volume":"274","author":"CL Sayas","year":"1999","unstructured":"Sayas CL, Moreno-Flores MT, Avila J, Wandosell F (1999) The neurite retraction induced by lysophosphatidic acid increases Alzheimer\u2019s disease-like Tau phosphorylation. J Biol Chem 274(52):37046\u201337052. https:\/\/doi.org\/10.1074\/jbc.274.52.37046","journal-title":"J Biol Chem"},{"issue":"3","key":"1719_CR141","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1474-4422(04)00683-0","volume":"3","author":"JC de la Torre","year":"2004","unstructured":"de la Torre JC (2004) Is Alzheimer\u2019s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 3(3):184\u2013190","journal-title":"Lancet Neurol"},{"issue":"6","key":"1719_CR142","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.kint.2016.11.010","volume":"91","author":"HY Li","year":"2017","unstructured":"Li HY, Oh YS, Choi JW, Jung JY, Jun HS (2017) Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db\/db mice. Kidney Int 91(6):1362\u20131373. https:\/\/doi.org\/10.1016\/j.kint.2016.11.010","journal-title":"Kidney Int"},{"issue":"2","key":"1719_CR143","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00018-006-6412-0","volume":"64","author":"NE Savaskan","year":"2007","unstructured":"Savaskan NE, Rocha L, Kotter MR, Baer A, Lubec G, van Meeteren LA, Kishi Y, Aoki J et al (2007) Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma. Cell Mol Life Sci 64(2):230\u2013243. https:\/\/doi.org\/10.1007\/s00018-006-6412-0","journal-title":"Cell Mol Life Sci"},{"key":"1719_CR144","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1742-2094-11-37","volume":"11","author":"PJ Crack","year":"2014","unstructured":"Crack PJ, Zhang M, Morganti-Kossmann MC, Morris AJ, Wojciak JM, Fleming JK, Karve I, Wright D et al (2014) Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes. J Neuroinflammation 11:37. https:\/\/doi.org\/10.1186\/1742-2094-11-37","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1719_CR145","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.ajpath.2012.06.007","volume":"181","author":"Y Goldshmit","year":"2012","unstructured":"Goldshmit Y, Matteo R, Sztal T, Ellett F, Frisca F, Moreno K, Crombie D, Lieschke GJ et al (2012) Blockage of lysophosphatidic acid signaling improves spinal cord injury outcomes. Am J Pathol 181(3):978\u2013992. https:\/\/doi.org\/10.1016\/j.ajpath.2012.06.007","journal-title":"Am J Pathol"},{"issue":"4","key":"1719_CR146","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10571-011-9650-0","volume":"31","author":"T Frugier","year":"2011","unstructured":"Frugier T, Crombie D, Conquest A, Tjhong F, Taylor C, Kulkarni T, McLean C, Pebay A (2011) Modulation of LPA receptor expression in the human brain following neurotrauma. Cell Mol Neurobiol 31(4):569\u2013577. https:\/\/doi.org\/10.1007\/s10571-011-9650-0","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"1719_CR147","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/1073858405285923","volume":"12","author":"AA Farooqui","year":"2006","unstructured":"Farooqui AA, Horrocks LA (2006) Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly. Neuroscientist 12(3):245\u2013260. https:\/\/doi.org\/10.1177\/1073858405285923","journal-title":"Neuroscientist"},{"issue":"4","key":"1719_CR148","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.bbrc.2018.05.106","volume":"501","author":"K Masago","year":"2018","unstructured":"Masago K, Kihara Y, Yanagida K, Hamano F, Nakagawa S, Niwa M, Shimizu T (2018) Lysophosphatidic acid receptor, LPA6, regulates endothelial blood-brain barrier function: Implication for hepatic encephalopathy. Biochem Biophys Res Commun 501(4):1048\u20131054. https:\/\/doi.org\/10.1016\/j.bbrc.2018.05.106","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"1719_CR149","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1097\/IAE.0000000000001112","volume":"36","author":"I Dacheva","year":"2016","unstructured":"Dacheva I, Ullmer C, Ceglowska K, Nogoceke E, Hartmann G, Muller S, Rejdak R, Nowomiejska K et al (2016) Lysophosphatidic acids and autotaxin in retinal vein occlusion. Retina 36(12):2311\u20132318. https:\/\/doi.org\/10.1097\/IAE.0000000000001112","journal-title":"Retina"},{"issue":"3","key":"1719_CR150","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/sj.mp.4001565","volume":"10","author":"C Aston","year":"2005","unstructured":"Aston C, Jiang L, Sokolov BP (2005) Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 10(3):309\u2013322. https:\/\/doi.org\/10.1038\/sj.mp.4001565","journal-title":"Mol Psychiatry"},{"issue":"4","key":"1719_CR151","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/ijnp\/pyz005","volume":"22","author":"K Itagaki","year":"2019","unstructured":"Itagaki K, Takebayashi M, Abe H, Shibasaki C, Kajitani N, Okada-Tsuchioka M, Hattori K, Yoshida S et al (2019) Reduced serum and cerebrospinal fluid levels of autotaxin in major depressive disorder. Int J Neuropsychopharmacol 22(4):261\u2013269. https:\/\/doi.org\/10.1093\/ijnp\/pyz005","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"1719_CR152","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.gene.2013.05.052","volume":"526","author":"A Manzardo","year":"2013","unstructured":"Manzardo A, Gunewardena S, Butler M (2013) Over-expression of the miRNA cluster at chromosome 14q32 in the alcoholic brain correlates with suppression of predicted target mRNA required for oligodendrocyte proliferation. Gene 526(2):356\u2013363","journal-title":"Gene"},{"issue":"6","key":"1719_CR153","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/acer.12429","volume":"38","author":"AM Manzardo","year":"2014","unstructured":"Manzardo AM, Gunewardena S, Wang K, Butler MG (2014) Exon microarray analysis of human dorsolateral prefrontal cortex in alcoholism. Alcohol Clin Exp Res 38(6):1594\u20131601. https:\/\/doi.org\/10.1111\/acer.12429","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"1719_CR154","doi-asserted-by":"publisher","first-page":"175909141666961","DOI":"10.1177\/1759091416669618","volume":"8","author":"NA Wheeler","year":"2016","unstructured":"Wheeler NA, Fuss B, Knapp PE, Zou S (2016) HIV-1 tat inhibits autotaxin lysophospholipase D activity and modulates oligodendrocyte differentiation. ASN Neuro 8(5):1759091416669618. https:\/\/doi.org\/10.1177\/1759091416669618","journal-title":"ASN Neuro"},{"issue":"1","key":"1719_CR155","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbalip.2014.09.004","volume":"1851","author":"RP Oude Elferink","year":"2015","unstructured":"Oude Elferink RP, Bolier R, Beuers UH (2015) Lysophosphatidic acid and signaling in sensory neurons. Biochim Biophys Acta 1851(1):61\u201365. https:\/\/doi.org\/10.1016\/j.bbalip.2014.09.004","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"1719_CR156","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/MPG.0000000000001044","volume":"62","author":"AE Kremer","year":"2016","unstructured":"Kremer AE, Gonzales E, Schaap FG, Oude Elferink RP, Jacquemin E, Beuers U (2016) Serum autotaxin activity correlates with pruritus in pediatric cholestatic disorders. J Pediatr Gastroenterol Nutr 62(4):530\u2013535. https:\/\/doi.org\/10.1097\/MPG.0000000000001044","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"1719_CR157","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1053\/j.gastro.2010.05.009","volume":"139","author":"AE Kremer","year":"2010","unstructured":"Kremer AE, Martens JJ, Kulik W, Rueff F, Kuiper EM, van Buuren HR, van Erpecum KJ, Kondrackiene J et al (2010) Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 139(3):1008\u20131018, 1018 e1001. https:\/\/doi.org\/10.1053\/j.gastro.2010.05.009","journal-title":"Gastroenterology"},{"issue":"4","key":"1719_CR158","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/hep.25748","volume":"56","author":"AE Kremer","year":"2012","unstructured":"Kremer AE, van Dijk R, Leckie P, Schaap FG, Kuiper EM, Mettang T, Reiners KS, Raap U et al (2012) Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology 56(4):1391\u20131400. https:\/\/doi.org\/10.1002\/hep.25748","journal-title":"Hepatology"},{"issue":"4","key":"1719_CR159","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jhep.2014.10.041","volume":"62","author":"AE Kremer","year":"2015","unstructured":"Kremer AE, Bolier R, Dixon PH, Geenes V, Chambers J, Tolenaars D, Ris-Stalpers C, Kaess BM et al (2015) Autotaxin activity has a high accuracy to diagnose intrahepatic cholestasis of pregnancy. J Hepatol 62(4):897\u2013904. https:\/\/doi.org\/10.1016\/j.jhep.2014.10.041","journal-title":"J Hepatol"},{"issue":"6","key":"1719_CR160","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/jid.2014.24","volume":"134","author":"Momoko Nakao","year":"2014","unstructured":"Nakao M, Sugaya M, Suga H, Kawaguchi M, Morimura S, Kai H, Ohmatsu H, Fujita H et al (2014) Serum autotaxin levels correlate with pruritus in patients with atopic dermatitis. 134. https:\/\/doi.org\/10.1038\/jid.2014.24","journal-title":"Journal of Investigative Dermatology"},{"issue":"1","key":"1719_CR161","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/hep.21271","volume":"44","author":"Ulrich Beuers","year":"2006","unstructured":"Beuers U, Gerken G, Pusl T (2006) Biliary drainage transiently relieves intractable pruritus in primary biliary cirrhosis [3]. 44. https:\/\/doi.org\/10.1002\/hep.21271","journal-title":"Hepatology"},{"issue":"5","key":"1719_CR162","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.ajpath.2014.01.029","volume":"184","author":"Y Shimizu","year":"2014","unstructured":"Shimizu Y, Morikawa Y, Okudaira S, Kimoto S, Tanaka T, Aoki J, Tokumura A (2014) Potentials of the circulating pruritogenic mediator lysophosphatidic acid in development of allergic skin inflammation in mice: role of blood cell-associated lysophospholipase D activity of autotaxin. Am J Pathol 184(5):1593\u20131603. https:\/\/doi.org\/10.1016\/j.ajpath.2014.01.029","journal-title":"Am J Pathol"},{"issue":"2","key":"1719_CR163","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0169-328X(99)00333-2","volume":"75","author":"K Renback","year":"2000","unstructured":"Renback K, Inoue M, Yoshida A, Nyberg F, Ueda H (2000) Vzg-1\/lysophosphatidic acid-receptor involved in peripheral pain transmission. Brain Res Mol Brain Res 75(2):350\u2013354","journal-title":"Brain Res Mol Brain Res"},{"issue":"3","key":"1719_CR164","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/MOG.0b013e32834575e8","volume":"27","author":"RP Oude Elferink","year":"2011","unstructured":"Oude Elferink RP, Kremer AE, Beuers U (2011) Mediators of pruritus during cholestasis. Curr Opin Gastroenterol 27(3):289\u2013293. https:\/\/doi.org\/10.1097\/MOG.0b013e32834575e8","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"1719_CR165","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12974-016-0612-9","volume":"13","author":"F Szepanowski","year":"2016","unstructured":"Szepanowski F, Derksen A, Steiner I, Meyer Zu Horste G, Daldrup T, Hartung HP, Kieseier BC (2016) Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling. J Neuroinflammation 13(1):143. https:\/\/doi.org\/10.1186\/s12974-016-0612-9","journal-title":"J Neuroinflammation"},{"issue":"2","key":"1719_CR166","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.canlet.2008.02.052","volume":"266","author":"LA van Meeteren","year":"2008","unstructured":"van Meeteren LA, Brinkmann V, Saulnier-Blache JS, Lynch KR, Moolenaar WH (2008) Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D. Cancer Lett 266(2):203\u2013208. https:\/\/doi.org\/10.1016\/j.canlet.2008.02.052","journal-title":"Cancer Lett"},{"issue":"12","key":"1719_CR167","doi-asserted-by":"publisher","first-page":"5604","DOI":"10.1021\/acs.jmedchem.5b01599","volume":"59","author":"D Castagna","year":"2016","unstructured":"Castagna D, Budd DC, Macdonald SJ, Jamieson C, Watson AJ (2016) Development of autotaxin inhibitors: an overview of the patent and primary literature. J Med Chem 59(12):5604\u20135621. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01599","journal-title":"J Med Chem"},{"issue":"9","key":"1719_CR168","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1021\/acs.jmedchem.7b00032","volume":"60","author":"N Desroy","year":"2017","unstructured":"Desroy N, Housseman C, Bock X, Joncour A, Bienvenu N, Cherel L, Labeguere V, Rondet E et al (2017) Discovery of 2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methyli midazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a first-in-class autotaxin inhibitor undergoing clinical evaluation for the treatment of idiopathic pulmonary fibrosis. J Med Chem 60(9):3580\u20133590. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00032","journal-title":"J Med Chem"},{"key":"1719_CR169","doi-asserted-by":"publisher","unstructured":"Fagard L, Desrivot J, Dupont S, Heckmann B, Blanque R, Gheyle L, Ralic J, Vanhoutte F Favorable human safety, pharmacokinetics and pharmacodynamics of the autotaxin inhibitor GLPG1690, a potential new treatment in idiopathic pulmonary fibrosis. In: A103. IPF: MORE ABOUT THERAPY AND OUTCOMES. pp A2701-A2701. https:\/\/doi.org\/10.1164\/ajrccm-conference.2016.193.1_MeetingAbstracts.A2701","DOI":"10.1164\/ajrccm-conference.2016.193.1_MeetingAbstracts.A2701"},{"key":"1719_CR170","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S2213-2600(18)30181-4","volume":"6","author":"TM Maher","year":"2018","unstructured":"Maher TM, van der Aar EM, Van de Steen O, Allamassey L, Desrivot J, Dupont S, Fagard L, Ford P et al (2018) Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial. Lancet Respir Med 6:627\u2013635","journal-title":"Lancet Respir Med"},{"issue":"10","key":"1719_CR171","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1194\/jlr.M039685","volume":"54","author":"AK Salous","year":"2013","unstructured":"Salous AK, Panchatcharam M, Sunkara M, Mueller P, Dong A, Wang Y, Graf GA, Smyth SS et al (2013) Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice. J Lipid Res 54(10):2775\u20132784. https:\/\/doi.org\/10.1194\/jlr.M039685","journal-title":"J Lipid Res"},{"issue":"4","key":"1719_CR172","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1194\/jlr.M056614","volume":"56","author":"M Navab","year":"2015","unstructured":"Navab M, Chattopadhyay A, Hough G, Meriwether D, Fogelman SI, Wagner AC, Grijalva V, Su F et al (2015) Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis. J Lipid Res 56(4):871\u2013887. https:\/\/doi.org\/10.1194\/jlr.M056614","journal-title":"J Lipid Res"},{"issue":"11","key":"1719_CR173","doi-asserted-by":"publisher","first-page":"e0143083","DOI":"10.1371\/journal.pone.0143083","volume":"10","author":"A Katsifa","year":"2015","unstructured":"Katsifa A, Kaffe E, Nikolaidou-Katsaridou N, Economides AN, Newbigging S, McKerlie C, Aidinis V (2015) The bulk of autotaxin activity is dispensable for adult mouse life. PLoS One 10(11):e0143083. https:\/\/doi.org\/10.1371\/journal.pone.0143083","journal-title":"PLoS One"},{"issue":"4","key":"1719_CR174","doi-asserted-by":"publisher","first-page":"e93230","DOI":"10.1371\/journal.pone.0093230","volume":"9","author":"H Saga","year":"2014","unstructured":"Saga H, Ohhata A, Hayashi A, Katoh M, Maeda T, Mizuno H, Takada Y, Komichi Y et al (2014) A novel highly potent autotaxin\/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tension. PLoS One 9(4):e93230. https:\/\/doi.org\/10.1371\/journal.pone.0093230","journal-title":"PLoS One"},{"issue":"6","key":"1719_CR175","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1096\/fj.13-248641","volume":"28","author":"MG Benesch","year":"2014","unstructured":"Benesch MG, Tang X, Maeda T, Ohhata A, Zhao YY, Kok BP, Dewald J, Hitt M et al (2014) Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice. FASEB J 28(6):2655\u20132666. https:\/\/doi.org\/10.1096\/fj.13-248641","journal-title":"FASEB J"},{"issue":"1","key":"1719_CR176","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.bbrc.2016.12.154","volume":"484","author":"S Aikawa","year":"2017","unstructured":"Aikawa S, Kano K, Inoue A, Aoki J (2017) Proliferation of mouse endometrial stromal cells in culture is highly sensitive to lysophosphatidic acid signaling. Biochem Biophys Res Commun 484(1):202\u2013208. https:\/\/doi.org\/10.1016\/j.bbrc.2016.12.154","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1719_CR177","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1096\/fj.14-262659","volume":"29","author":"G Venkatraman","year":"2015","unstructured":"Venkatraman G, Benesch MG, Tang X, Dewald J, McMullen TP, Brindley DN (2015) Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment. FASEB J 29(3):772\u2013785. https:\/\/doi.org\/10.1096\/fj.14-262659","journal-title":"FASEB J"},{"issue":"3","key":"1719_CR178","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1124\/jpet.108.141911","volume":"327","author":"G Ferry","year":"2008","unstructured":"Ferry G, Moulharat N, Pradere JP, Desos P, Try A, Genton A, Giganti A, Beucher-Gaudin M et al (2008) S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool. J Pharmacol Exp Ther 327(3):809\u2013819. https:\/\/doi.org\/10.1124\/jpet.108.141911","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"1719_CR179","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/cmdc.201000425","volume":"6","author":"R Gupte","year":"2011","unstructured":"Gupte R, Patil R, Liu J, Wang Y, Lee SC, Fujiwara Y, Fells J, Bolen AL et al (2011) Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity. ChemMedChem 6(5):922\u2013935. https:\/\/doi.org\/10.1002\/cmdc.201000425","journal-title":"ChemMedChem"},{"issue":"2","key":"1719_CR180","doi-asserted-by":"publisher","first-page":"617","DOI":"10.4049\/jimmunol.1400565","volume":"193","author":"T Katakai","year":"2014","unstructured":"Katakai T, Kondo N, Ueda Y, Kinashi T (2014) Autotaxin produced by stromal cells promotes LFA-1-independent and Rho-dependent interstitial T cell motility in the lymph node paracortex. J Immunol 193(2):617\u2013626. https:\/\/doi.org\/10.4049\/jimmunol.1400565","journal-title":"J Immunol"},{"key":"1719_CR181","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1476-4598-10-18","volume":"10","author":"S Li","year":"2011","unstructured":"Li S, Wang B, Xu Y, Zhang J (2011) Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis. Mol Cancer 10:18. https:\/\/doi.org\/10.1186\/1476-4598-10-18","journal-title":"Mol Cancer"},{"issue":"8","key":"1719_CR182","doi-asserted-by":"publisher","first-page":"e42627","DOI":"10.1371\/journal.pone.0042627","volume":"7","author":"P Iyer","year":"2012","unstructured":"Iyer P, Lalane R 3rd, Morris C, Challa P, Vann R, Rao PV (2012) Autotaxin-lysophosphatidic acid axis is a novel molecular target for lowering intraocular pressure. PLoS One 7(8):e42627. https:\/\/doi.org\/10.1371\/journal.pone.0042627","journal-title":"PLoS One"},{"issue":"5","key":"1719_CR183","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nsmb.3200","volume":"23","author":"K Kato","year":"2016","unstructured":"Kato K, Ikeda H, Miyakawa S, Futakawa S, Nonaka Y, Fujiwara M, Okudaira S, Kano K et al (2016) Structural basis for specific inhibition of autotaxin by a DNA aptamer. Nat Struct Mol Biol 23(5):395\u2013401. https:\/\/doi.org\/10.1038\/nsmb.3200","journal-title":"Nat Struct Mol Biol"},{"issue":"16","key":"1719_CR184","doi-asserted-by":"publisher","first-page":"14522","DOI":"10.18632\/oncotarget.3995","volume":"6","author":"JM Woodcock","year":"2015","unstructured":"Woodcock JM, Coolen C, Goodwin KL, Baek DJ, Bittman R, Samuel MS, Pitson SM, Lopez AF (2015) Destabilisation of dimeric 14-3-3 proteins as a novel approach to anti-cancer therapeutics. Oncotarget 6(16):14522\u201314536. https:\/\/doi.org\/10.18632\/oncotarget.3995","journal-title":"Oncotarget"},{"issue":"2","key":"1719_CR185","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nsmb.1980","volume":"18","author":"J Hausmann","year":"2011","unstructured":"Hausmann J, Kamtekar S, Christodoulou E, Day JE, Wu T, Fulkerson Z, Albers HM, van Meeteren LA et al (2011) Structural basis of substrate discrimination and integrin binding by autotaxin. Nat Struct Mol Biol 18(2):198\u2013204. https:\/\/doi.org\/10.1038\/nsmb.1980","journal-title":"Nat Struct Mol Biol"},{"issue":"13","key":"1719_CR186","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1021\/jm200310q","volume":"54","author":"HM Albers","year":"2011","unstructured":"Albers HM, Hendrickx LJ, van Tol RJ, Hausmann J, Perrakis A, Ovaa H (2011) Structure-based design of novel boronic acid-based inhibitors of autotaxin. J Med Chem 54(13):4619\u20134626. https:\/\/doi.org\/10.1021\/jm200310q","journal-title":"J Med Chem"},{"issue":"40","key":"1719_CR187","doi-asserted-by":"publisher","first-page":"34654","DOI":"10.1074\/jbc.M111.276725","volume":"286","author":"Z Fulkerson","year":"2011","unstructured":"Fulkerson Z, Wu T, Sunkara M, Kooi CV, Morris AJ, Smyth SS (2011) Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells. J Biol Chem 286(40):34654\u201334663. https:\/\/doi.org\/10.1074\/jbc.M111.276725","journal-title":"J Biol Chem"},{"issue":"Pt A","key":"1719_CR188","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.phrs.2016.09.025","volume":"113","author":"WS Chew","year":"2016","unstructured":"Chew WS, Wang W, Herr DR (2016) To fingolimod and beyond: the rich pipeline of drug candidates that target S1P signaling. Pharmacol Res 113(Pt A):521\u2013532. https:\/\/doi.org\/10.1016\/j.phrs.2016.09.025","journal-title":"Pharmacol Res"},{"issue":"22","key":"1719_CR189","doi-asserted-by":"publisher","first-page":"21155","DOI":"10.1074\/jbc.M413183200","volume":"280","author":"LA van Meeteren","year":"2005","unstructured":"van Meeteren LA, Ruurs P, Christodoulou E, Goding JW, Takakusa H, Kikuchi K, Perrakis A, Nagano T et al (2005) Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate. J Biol Chem 280(22):21155\u201321161. https:\/\/doi.org\/10.1074\/jbc.M413183200","journal-title":"J Biol Chem"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01719-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-01719-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01719-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T21:19:42Z","timestamp":1664054382000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-01719-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":189,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1719"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01719-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]},"assertion":[{"value":"16 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}